4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-039239
Director sold 1,000 shares at $13.15 ($13,150)
- Director acquired 5,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Carol Giltner Director | 2017-06-08 | Grant or award | +5,000 | 108,374 | D | ||
| Gallagher Carol Giltner Director | 2017-06-09 | Sale | −1,000 | $13.15 | $13,150 | 107,374 | D |
| Derivatives | |||||||
| Gallagher Carol Giltner Director | 2017-06-08 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +21,500 | 21,500 | D | ||
| Open-market sales · 1,000 sh · avg $13.15 · $13,150 | |||||||
Loading xslF345X03/doc4.xml…